Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Dermatologic 1

Conditions

Lung Neoplasms 84Carcinoma, Non-Small-Cell Lung 61Melanoma 13Neoplasm Metastasis 12Small Cell Lung Carcinoma 11Breast Neoplasms 10Colorectal Neoplasms 9Carcinoma, Renal Cell 8Ovarian Neoplasms 7Carcinoma, Hepatocellular 7Prostatic Neoplasms 6Pancreatic Neoplasms 6Brain Neoplasms 5Adenocarcinoma of Lung 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Sarcoma, Kaposi 4Meningeal Carcinomatosis 4Esophageal Neoplasms 4Carcinoma, Transitional Cell 4Triple Negative Breast Neoplasms 3HIV Infections 3Endometrial Neoplasms 3Uveal Melanoma 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Rectal Neoplasms 2Multiple Myeloma 2Fallopian Tube Neoplasms 2

Interventions

Spinal Puncture 2sapanisertib 1Specimen Handling 1Phlebotomy 1Nivolumab 1Magnetic Resonance Spectroscopy 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningeal Neoplasms × Specimen Handling × Thoracic × Clear all
NCT03025256 2026-05-05

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase 1 Recruiting
75 enrolled
DermatologicThoracic

Uveal Melanoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Meningeal Neoplasms, Nevus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡